Itraconazole for antifungal prophylaxis in neutropenic patients: An update of a meta-analysis with now 3846 patients.

被引：0
|
作者：
Glasmacher, A
Hahn, C
von Lilienfeld-Toal, M
Orlopp, K
Schmidt-Wolf, I
Prentice, A
机构：
[1] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany
[2] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3224
引用
收藏
页码：901A / 901A
页数：1
相关论文
共 50 条
  • [31] Antifungal prophylaxis for patients undergoing chemotherapy or haematopoeitic stem cell transplantation - meta-analysis
    Robenshtok, E.
    Gafter-Gvili, A.
    Paul, M.
    Goldberg, E.
    Vidal, L.
    Leibovici, L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S254 - S254
  • [32] Antifungal prophylaxis in neutropenia cancer patients: A meta-analysis of randomized controlled trials.
    Bow, EJ
    Laverdiere, M
    Lussier, N
    Rotstein, C
    Cheang, MS
    Ioannou, S
    BLOOD, 1999, 94 (10) : 339A - 339A
  • [33] Antifungal prophylaxis for severely neutropenic chemotherapy recipients -: A meta-analysis of randomized-controlled clinical trials
    Bow, EJ
    Laverdiére, M
    Lussier, N
    Rotstein, C
    Cheang, MS
    Ioannou, S
    CANCER, 2002, 94 (12) : 3230 - 3246
  • [34] Medical costs analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: A systematic review analysis
    Shintani, Takamichi
    Imataki, Osamu
    Ohnishi, Hiroaki
    Kitanaka, Akira
    Kubota, Yoshitsugu
    Tanaka, Terukazu
    Ishida, Toshihiko
    BLOOD, 2007, 110 (11) : 979A - 979A
  • [35] Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis
    Imataki, Osamu
    Kubota, Yoshitsugu
    Ohnishi, Hiroaki
    Kitanaka, Akira
    Ishida, Toshihiko
    Tanaka, Terukazu
    SUPPORTIVE CARE IN CANCER, 2011, 19 (10) : 1657 - 1665
  • [36] Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis
    Osamu Imataki
    Yoshitsugu Kubota
    Hiroaki Ohnishi
    Akira Kitanaka
    Toshihiko Ishida
    Terukazu Tanaka
    Supportive Care in Cancer, 2011, 19 : 1657 - 1665
  • [37] Use of itraconazole as prophylaxis of systemic aspergillosis in neutropenic patients : interest of drug monitoring
    Cheymol, G
    Poirier, JM
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1999, 183 (02): : 371 - 381
  • [38] Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients (vol 142, pg 979, 2005)
    Gafter-Gvili, A
    Fraser, A
    Paul, M
    Leibovici, L
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (09) : 704 - 704
  • [39] Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies:: Evidence from a meta-analysis of 3,597 patients
    Glasmacher, A
    Prentice, A
    Gorschlüter, M
    Engelhart, S
    Hahn, C
    Djulbegovic, B
    Schmidt-Wolf, IGH
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4615 - 4626
  • [40] Intravenous followed by oral itraconazole versus intravenous amphotericin B as empirical antifungal therapy for febrile neutropenic haematological cancer patients.
    Ehninger, G
    Schuler, UE
    Bammer, S
    Aulitzky, WE
    Binder, C
    Boehme, A
    Egerer, G
    Ganser, A
    Peschel, C
    Schwerdtfeger, R
    Silling, G
    Zander, AR
    Wandt, H
    BLOOD, 2002, 100 (11) : 42B - 42B
12345